BioSpace News Archive

Sorrento Therapeutics, Inc. today announced that COVID-19 patients have been dosed in its Phase 2 efficacy trial.

Pressure BioSciences, Inc. today announced it has established a wholly-owned agrochemicals subsidiary named PBI Agrochem, Inc.

Kazia Therapeutics Limited, a leading drug development company in the field of brain cancer, recognizes Glioblastoma Awareness Day and calls for a greater focus on research from industry, academia, and government in order to better treat the disease.

Venock is developing a vascular closure system for large bore punctures (up to 30 Fr and larger) in vessels following transvenous catheter-based therapies such as atrial ablations, leadless pacemaker implantations, ECMO, and various structural heart therapies such as Mitral- and Tricuspid- Valve Repair and Replacement.

MB-204 is the Company’s lead compound with potential application to the neurological diseases of depression & anxiety, Alzheimer’s, ADHD and non-neurological diseases such as cancer and non-alcoholic steatohepatitis.

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia

The market is estimated to grow with a CAGR of 4.5% from 2016-2025.

The Gene synthesis market was valued at US$ 3,991.23 million in 2017 and it is projected to reach US$ 107,797.82 million by 2025; it is expected to grow at a CAGR of 28.7% from 2017 to 2025.

The medical adhesive and sealants market is expected to reach US$ 17,468.1 million in 2027 from US$ 9,867.9 million in 2019.

The Medical Robots market is projected to reach US$ 28,776.5 million by 2025 from US$ 5,740.8 million in 2017; it is expected to grow at a CAGR of 22.3% from 2017 to 2025. The Medical Robots market is projected to reach US$ 28,776.5 million by 2025 from US$ 5,740.8 million in 2017; it is expected to grow at a CAGR of 22.3% from 2017 to 2025.